DOI: 10.36347/sjmcr.2016.v04i12.031

Pages: 982-985

De novo cancer is the most common cause of death in renal transplant recipients. The immunosuppression for renal transplantation is the reason for de novo carcinogenesis and most of the immunosuppressant agents used for renal transplantation was shown to produce similar risks for carcinogenicity after kidney transplantation. The most common de novo cancer is skin cancer in the follow up of renal transplant recipients and the de novo solid organ cancers are relatively rare. Renal cancers were reported to be present up to 9-17% in the follow up of renal transplant recipients. It is the native kidney to have the de novo cancer mostly (85-100%). In this case report we present a male renal transplant recipient who developed native kidney RCC after 5 years of transplantation with radiological, macroscopic and microscopic images.